Archive for June 30th, 2009

Alternative, complementary, natural, and homeopathic.

Link:  http://www.boston.com/news/health/articles/2009/06/29/the_risks_and_rewards_of_all_natural_supplements/

Boston Globe, 6/29/09

The allure is undeniable. Stroll into a store, pluck a remedy branded “all-natural’’ from the shelf, and pay the price tattooed on the bottle. No insurance card, no prescription, no doctor appointment required.

But there’s also no guarantee that what you’re buying will cure your cold, silence your arthritis, or calm your nerves. And it might even spark serious side effects – especially if an otherwise innocuous herb is taken with a powerful prescription pill, producing a toxic brew.

This month, an over-the-counter cold treatment called Zicam landed in the cross hairs of the US Food and Drug Administration after the agency received more than 100 reports of users losing their ability to smell – sometimes briefly, sometimes permanently. The FDA’s advice: Stop using Zicam sprays and gels. Immediately. It was the latest cautionary tale about products that, in the main, fly under the radar of regulatory agencies whose main job is approving and monitoring prescription medications.

Americans spend billions of dollars annually on pills, herbs, and other medical products known variously as alternative, complementary, natural, and homeopathic. And the users – including some traditionally trained physicians – swear by them, even if federal drug regulators don’t. Manufacturers argue that many of the products – especially herbs – have survived the crucible of time, used through the ages without complaint. Consumer advocates counter that longevity is no substitute for gold-standard scientific evidence.

This much is clear: More than five years after the FDA banished an herbal weight-loss compound called ephedra that was blamed for 155 deaths, the love affair with supplements blazes hotter than ever. Never has it been more important for patients and doctors alike to understand the potential promise and peril carried in the amber bottles of hope stocked on bulging shelves.

“You’ll find one person who says this is the next best thing since sliced bread, and somebody else who says this will kill you. But, really, the truth is somewhere between,’’ said Candy Tsourounis, a professor of clinical pharmacy at the University of California-San Francisco. “So how does a consumer get the truth from these two polar opposites? It’s going to the right provider, asking the right questions, being informed.’’

When Dr. Benjamin Kruskal encounters patients for the first time in his Somerville office, he lets them know he harbors no hostility toward alternative medicine.

“The biggest thing I communicate to people is caution and looking hard for evidence about safety – above all else, safety first,’’ said Kruskal, who practices at Harvard Vanguard Medical Associates. “And I do encourage people to tell me what they’re using. A lot of people say, ‘I’m taking vitamins, that doesn’t count as a medicine.’ But if they’re taking 3 grams of vitamin C, it sure does count as medicine.’’

It’s important for physicians to know whether patients are taking herbs or other products that can react powerfully with prescription medications, sometimes amplifying the effect of those drugs, sometimes muting it.

For instance, the herb St. John’s wort, which has been shown in some scientific studies to alleviate depression, can impair the liver’s ability to process certain drugs. That’s why HIV patients taking medication called protease inhibitors are urged not to use the herb. There’s also evidence that St. John’s wort can make birth control pills less effective.

Patients who take the blood- thinning drug Coumadin – sometimes prescribed after a heart attack or stroke – are told to be especially forthright with their doctors when discussing supplements they take, because some over-the-counter products have been shown to alter the medication’s function.

Herbs and homeopathic products, the class that includes Zicam, do not have to undergo elaborate, expensive scientific studies proving they work before they can be marketed – unlike prescription medications. Nor do they require the FDA’s approval, although manufacturers must promptly alert regulators if they receive reports of serious side effects linked to their products.

(Of course, as scandals with some prescription drugs have so clearly demonstrated – think Vioxx – the FDA’s approval process is hardly foolproof.)

Companies that make supplements and herbs, much like food processors, are required to hew to good manufacturing practices. But those rules are no assurance that the ginkgo you buy in one shop is the same strength as the ginkgo peddled down the street.

“One thing we can say for sure is if consumers are contemplating using a medication, they should familiarize themselves quite well with what’s on the label,’’ said Dr. Charles Lee, an FDA medical officer.

Evidence that supplements truly help is spotty – and, sometimes, bewilderingly mixed.

Consider the widely used herb echinacea, heralded for its purported ability to dampen, or even prevent, respiratory infections. Scientists at the National Center for Complementary and Alternative Medicine – it has a trove of information at www.nccam.nih.gov – declare that when it comes to preventing colds or the flu, echinacea is a bust.

The findings are more equivocal regarding the herb’s ability to treat a cold once it has already settled in. While two studies funded by the federal agency concluded there was no evidence echinacea can ease a cold, other studies have shown it may indeed help.

“The issue is this,’’ said Dr. Sidney Wolfe, acting president of Public Citizen, a leading consumer advocacy group whose research has seared prescription products as well as alternative supplements: “Anything that is supposed to affect the human body should have scientific evidence that it affects the human body in a good way and that it is safe.’’

Michael McGuffin, president of the American Herbal Products Association, a trade alliance, has an answer for Wolfe: Pay attention to history.

“If I’m marketing an herbal ingredient that’s used for a purpose that’s known and consistent for hundreds of years . . . do I need’’ a gold-standard scientific trial, McGuffin asked. “I don’t think so. I have respect for these uses that have been recorded for centuries. I just don’t see that there’s a need for a new scientific model to confirm what we already know from experience.’’

Sometimes, deciding whether to use a supplement for a relatively minor ailment comes down to an exquisite balancing of benefit and risk.

Such was the case with Dr. Rick McKinney, who melds mainstream health practices with the less conventional approaches favored by some of his patients. A few years back, the fog of a cold descended upon him.

He could have just soldiered on, enduring the drip, drip, drip. But a buddy had touted Zicam. “By God, it worked – it was a huge reduction in the nuisance symptoms of the common cold,’’ said McKinney, a UC-San Francisco physician who acknowledges his was a scientifically irrelevant “study of one.’’

It proved to be the only time he used the spray. McKinney decided to dig a little and discovered that some Zicam users reported losing their sense of smell after squirting the zinc-laced compound up their nostrils.

“I wasn’t willing to take the chance,’’ McKinney said. “If this was a chance to cure me of cancer, sign me up. But this was a chance I was taking to avoid nuisance-level symptoms and not something that was going to make me live any longer – even if it worked well.’’

Stephen Smith can be reached at stsmith@globe.com.

© Copyright 2009 Globe Newspaper Company.

Boomerang Re-Admissions

Link:  http://www.washingtonpost.com/wp-dyn/content/article/2009/06/29/AR2009062903134.html

Washington Post, 6/29/09

Doctors call them frequent fliers.

They are the patients who leave the hospital, only to boomerang back days or weeks later. They have become a front-burner challenge not only for hospitals and doctors but also for those trying to rein in rising costs.

Typically elderly and suffering from the chronic diseases that account for 75 percent of health-care spending, their experiences of being readmitted time and again reflect many of the deficiencies in a fragmented, poorly coordinated health system geared toward acute care.

Take Margaret White. With better management of her congestive heart failure, she might have avoided being rehospitalized this spring for five days. She’s back home again now, doing well, with help from a new monitoring program at Inova Mount Vernon Hospital in Alexandria.

There are many reasons for readmissions, including high rates of medical errors and hospital-acquired infections; lack of communication between doctors who care for patients in the hospital and their regular physicians; trouble getting a prompt doctor’s appointment after discharge; missed referrals for home health care; and poor coordination and medication management during transitions from hospital to home or nursing home.

“Transitions are just so dangerous. Every time you move a patient from one setting or facility to another, you have to ask, ‘Is something going to go wrong?’ ” said Joan Teno, a geriatrician at Brown University Medical School, who has often treated her patients in nursing homes for conditions that otherwise would propel them back to the hospital. Teno said the ways nursing homes are paid mean it’s often easier for them to let the hospitals take care of sick patients.

Experts don’t agree on how many readmissions are avoidable. Dozens of promising initiatives designed to cut down on them are underway. But many experts say sweeping changes are needed in how health care is delivered and how hospitals and doctors are paid — sensitive issues that confront Congress and the medical industry in the debate on overhauling the health system.

President Obama and health reformers in Congress are looking at many ways to reward quality and emphasize prevention and coordination. Right now, hospitals — such as Inova Mount Vernon — that do a better job of preventing readmissions sometimes end up losing money because the health-care system doesn’t pay for the extra work they do. Some health reform proposals would change the way hospitals are paid, so that stopping readmissions becomes good business.

One idea is to bundle the payments to hospitals, doctors and perhaps nursing homes or rehabilitation centers, to cover both the hospitalization and those first critical weeks after discharge.

Another proposal is to have Medicare penalize hospitals with high readmission rates for eight common chronic diseases. Members of both parties have been looking at ways of paying primary care doctors more to help patients manage their chronic diseases and avoid trips to the hospital every few weeks or months.

Both doctors groups and the American Hospital Association have agreed that it’s time to address readmissions. The association, however, prefers to start with pilot programs to test new payment systems rather than implementing an across-the-board new approach. The AHA also says hospitals should not be held responsible for problems that patients encounter when they’re outside the hospitals’ control.

Readmission costs are staggering. One of five Medicare hospital patients returns to the hospital within 30 days — at a cost to Medicare of $12 billion to $15 billion a year — and by 90 days the rate rises to one of three, according to an analysis of 2007 data by Stephen Jencks. Within a year, two out of three are back in the hospital — or dead. Jencks consults on this issue for the independent Massachusetts-based Institute for Healthcare Improvement.

For the population as a whole, including patients too young for Medicare, the readmission rate is 14 to 19 percent for the first 30 days, said Jencks.

One tactic used by Inova Mount Vernon is to change the way it deals with some discharged patients.

For example, the hospital began its HeartLink program in November, after Honora Fowler, a nurse, and Lynne Weir, a physical therapist who specializes in cardiac rehabilitation, brainstormed about how to help their congestive heart failure patients take better care of themselves.

Patients monitor themselves daily and call a toll-free telephone line to answer some simple questions about weight gain, swelling and breathing difficulties.

Fowler reviews the answers to see whom she needs to call, whom she needs to keep an eye on for a day or two, who needs their medications adjusted and who better get in to see a doctor right away. Occasionally, with a patient with advanced disease, she calls a case worker or doctor to suggest it’s time to have a gentle conversation about palliative care or hospice.

White’s first hospitalization for her heart disease was last September, before HeartLink was up and running. When she returned this spring, her cardiologist talked to her about HeartLink.

“I hadn’t been paying attention to the fluids. In fact, when I gained the weight, I didn’t realize it was all fluid, I thought it was good, that I was regaining the weight I had lost” during treatment a year earlier for breast cancer, said White, 59. Now she weighs herself daily, checks her feet for swelling, pays attention to changes in her breathing, and calls it all in to HeartLink, which Inova offers at no charge.

After months of barely getting out of bed, White has started a small summer vegetable garden on her balcony in Alexandria.

“We catch problems faster,” Fowler said. Because the patients and their families trust her, she can find out what went wrong and how to stop it. Sometimes it’s as simple as persuading a heart failure patient that it’s not okay to splurge occasionally on a bacon double-cheeseburger.

Some doctors are skeptical of this new stress on avoidable hospitalizations. At an American Medical Association meeting in Washington this year, some questioned whether they could do much to reduce hospitalizations. Cases can be very complicated, they said; patients don’t always follow directions.

HeartLink is new and small, and the results are anecdotal and preliminary. But other hospitals and doctors say they’re proving that innovative approaches can cut readmissions while providing higher-quality care at lower cost.

At Saint Luke’s Hospital in Cedar Rapids, Iowa, nurse Peggy Bradke and her team use a simple “Teach Back” system to make sure that patients or a family member truly understand all the medications and treatments needed at home.

Instead of going home with a sheaf of incomprehensible discharge instructions, patients leave St. Luke’s with simple information, a refrigerator magnet with danger signs, a phone number they can call day or night and an appointment with their doctor, preferably within three to five days. Making that appointment is essential. Jencks’s research has shown that half the patients who are readmitted within a month hadn’t seen a doctor after leaving the hospital.

Then, even though it’s not paid for by Medicare or other insurance, St. Luke’s sends a nurse to the patient’s home at no charge 24 to 48 hours after discharge, and follows up later with a phone call.

“We’ve had some great catches,” said Bradke. “We find a shoebox full of meds that is completely different from what we thought they were taking in the hospital. Or we find that one of the hospital prescriptions wasn’t filled or [was] not delivered.”

Bradke’s team intervened when Frederick Peterson, 72, a “frequent flier” who has lost track of how many times he has been admitted, returned to the hospital yet again in January. Among his many health problems, Peterson has had congestive heart failure for a decade, which he has not always controlled well. Sometimes he has gone back into the hospital just days after being discharged.

“A nurse came home and went over all my medications. She even went over the labels in our canned food,” Peterson said. “I knew salt was bad, but I still used it. But this nurse explained it more thoroughly and now we don’t use salt.”

St. Luke’s three-year-old program has cut the hospital’s 30-day readmission rate for congestive heart failure patients in half, from 12 to 6 percent. The goal is to bring it to 4 percent. Even when patients do return to the hospital, they tend to have shorter stays and less severe illness.

Pat Rutherford, a vice president at the Institute for Healthcare Improvement, has been working with hospitals across the country that want to see less of their frequent fliers.

“There are a lot of innovations out there, and we have growing evidence that we can improve this for the patient, to make their experience better and make sure they have a better handoff to a home or community setting,” she said.

“How many hospitals are ready to step up to the plate? That’s to be determined,” she added. “But more and more are becoming aware that in terms of quality and cost, this could be a huge home run if we do it right.”

This story was produced through a collaboration between The Post and Kaiser Health News. KHN is a service of the Kaiser Family Foundation, a nonpartisan health-care-policy research organization unaffiliated with Kaiser Permanente. Comments: health@washpost.com.

 

 

OMNI Postings of 6/30/09

Bernie Madoff:  What’s that?

Guard:  That’s your new home, 983867.

Bernie:  It’s only one room!

Guard:  But it’s very efficient.  You can eat, read, sleep, take a crap without exerting yourself.

Bernie:  You mean that’s my bed?

Guard:  Yep.

Bernie:  Sheets?

Guard:  Yep.

Bernie:  How many threads per square inch?

Guard:  Two.

Bernie:  But I have tender skin!

Guard:  Yeah, a couple of the inmates noticed.  I wouldn’t bend over for the soap.

Bernie:  And that?

Guard:  What?

Bernie:  That contraption with the hole.

Guard:  Your toilet.

Bernie:  You mean that’s where I’m supposed to do number 1 and 2?

Guard:  And 3 and 4 for all I care.

Bernie:  But there’s no seat.

Guard:  Make believe.

Bernie:  But the toilet paper has wood splinters in it!

Guard:  That’s a present from the warden.  He lost $3.6 million from your Ponzi scheme.

But I digress……

It’s official.  The FDA confirmed that they found E. coli in the cookie dough.  They also found Michael Jackson’s other glove!
http://omniphysicians.com/2009/06/30/e-coli-cookie-dough/ 

The big news today is that  walkers and canes can be dangerous.  According to CDC, from 2001 to 2006, a total of more than 47,000 oldsters each year came to the ED for injuries from falls that involved walkers and canes.  That’s something Michael Jackson won’t have to worry about anymore.
http://omniphysicians.com/2009/06/29/walkers-and-canes-can-be-hazardous-to-ones-health/

Here’s the latest map of the world showing where all the H1N1 cases are located.  It’s ironic, but apart from Antarctica, the one other continnt that seems to be largely protected from the pandemic is Africa.  Meanwhile, the North American continent looks like a cesspool of swine flu.
http://omniphysicians.com/2009/06/29/who-h1n1-map-of-the-world/

This study published in Pediatrics looked at acute sinusitis in kids and the use of antibiotics.  It was a randomized, double-blind, placebo-controlled study, but the study population included subjects who were thought to have acute bacterial sinusitis based on clinical findings.  Children receiving the antibiotic were more likely to be cured (50% vs 14%) and less likely to have treatment failure (14% vs 68%) than children receiving the placebo.  And the best antibiotic was Augmentin.
http://omniphysicians.com/2009/06/29/amoxicillinclavulanate-potassium-in-the-treatment-of-acute-bacterial-sinusitis-in-children/

Paul R

E. coli & Cookie Dough

For Immediate Release: June 29, 2009

Media Inquiries: Stephanie Kwisnek, 301-796-4737, Stephanie.Kwisnek@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA CONFIRMS E. COLI O157:H7 IN PREPACKAGED NESTLÉ TOLL HOUSE REFRIGERATED COOKIE DOUGH

Today, the U.S. Food and Drug Administration announced that it has found E. coli O157:H7 (a bacterium that can cause serious food borne illness) in a sample of prepackaged Nestlé Toll House refrigerated cookie dough currently under recall by the manufacturer and marketer, Nestlé USA.  The contaminated sample was collected at Nestlé’s facility in Danville, Va. on June 25, 2009. 

On June 19, the FDA and the U.S. Centers for Disease Control and Prevention warned consumers not to eat any varieties of prepackaged Nestlé Toll House refrigerated cookie dough due to the risk of contamination with E. coli O157:H7.  The warning was based on an epidemiological study conducted by the CDC and several state and local health departments. As of Thursday, June 25, the CDC reports that 69 persons from 29 states have been infected with the outbreak strain. Thirty-four persons have been hospitalized, nine with a severe complication called hemolytic uremic syndrome. No one has died.

Further laboratory testing is needed to conclusively link the E. coli strain found in the product to the same strain that is causing the outbreak.

Nestlé USA has fully cooperated with the FDA and CDC investigation and has recalled all of its prepackaged Nestlé Toll House refrigerated cookie dough products.

For answers to consumer questions about this recall and warning, go to: http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm168346.htm.

For more information about E. coli, visit the CDC Web site at: http://www.cdc.gov/ecoli/.

Consumers who have additional questions about these products should contact Nestlé USA consumer services at 1-800-559-5025 and/or visit its Web site at www.verybestbaking.com.exit icon